BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19157151)

  • 1. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
    Li S; Zhan H; Peng S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
    Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
    Li H; Jiang P; Wang L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
    Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
    Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
    Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
    Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR expression in acquired middle ear cholesteatoma in children and adults.
    Alves AL; Pereira CS; Carvalho Mde F; Fregnani JH; Ribeiro FQ
    Eur J Pediatr; 2012 Feb; 171(2):307-10. PubMed ID: 21800041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the gap junction proteins connexin 26 and connexin 43 in human middle ear cholesteatoma.
    Choung YH; Park K; Kang SO; Markov Raynov A; Ho Kim C; Choung PH
    Acta Otolaryngol; 2006 Feb; 126(2):138-43. PubMed ID: 16428189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Markers of epidermal proliferation in middle ear cholesteatoma].
    Hassmann-Poznańska E; Skotnicka B; Dziecioł J
    Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma.
    Ergün S; Zheng X; Carlsöö B
    Am J Otol; 1996 May; 17(3):393-6. PubMed ID: 8817015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
    Li Z; Li X; Liu G
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of hypoxia-inducible factor-1alpha in middle ear cholesteatoma].
    Liu Y; Cui Y; Yu L; Zhang P
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(1):4-6. PubMed ID: 15830692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma.
    Liu W; Ren H; Ren J; Yin T; Hu B; Xie S; Dai Y; Wu W; Xiao Z; Yang X; Xie D
    Mediators Inflamm; 2013; 2013():651207. PubMed ID: 24311896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
    Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression of Ras protein in human middle ear cholesteatoma].
    Xu Y; Jin K; Dong W
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
    Peng L; Cui Y; Liu A
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
    Zhu Z; Hong Y; Wang Y; He G; Ye S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(2):139-43. PubMed ID: 27192911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection and correlation of lipopolysaccharide, vitamin D receptor and matrix metalloproteinase-9 in the middle ear cholesteatoma].
    Li Y; Xu Z; Zhang L; Quan C; Lin X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):739-41, 746. PubMed ID: 23213753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.